NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased NuScale Power Corporation (“NuScale” or the “Company”) (NYSE:SMR) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your NuScale investments, you have until April 20, 2026 to request lead plaintiff appointment. C ...

Core Viewpoint - A class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. for alleged misleading statements and failure to disclose critical information regarding its CELLECTRA device and the INO-3107 Biologics License Application [2][5]. Allegation Details - The lawsuit claims that during the Class Period, Inovio made false statements about the manufacturing quality of its CELLECTRA device, which impacted the likelihood of submitting the INO-3107 BLA to the FDA by the second half of 2024 [5]. - It is alleged that Inovio lacked sufficient information to support the eligibility of the INO-3107 BLA for FDA accelerated approval or priority review, leading to overstated regulatory and commercial prospects [5]. - The lawsuit asserts that when the true information became public, investors suffered financial damages, particularly after the FDA's announcement regarding the BLA's acceptance on a standard review timeline rather than accelerated approval [5]. Stock Price Impact - Following the FDA's announcement on December 29, 2025, Inovio's stock price dropped by $0.56 per share, representing a decline of 24.45%, closing at $1.73 per share [5].

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Apollo Global Management, Inc. (NYSE: APO) resulting from allegations that Apollo may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Apollo securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company” or “Cannabix”) announces it has closed its previously announced non-brokered private placement financing (the "Offering") with the issuance of 1,400,000 units of the Company (the “Units”) at an issue price of CDN$0.50 per Unit for aggregate gross proceeds of CDN$700,000. Each Unit consists of one ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Brag ...

DALLAS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (Nasdaq: BLBX) (“Blackboxstocks”) today announced the successful closing of its previously announced merger with REalloys Inc. (“REalloys”) following the close of market on February 24, 2026. Effective at the open of trading on Wednesday, February 25, 2026, the combined company will operate under the name REalloys Inc. and its common stock is expected to trade on the Nasdaq Capital Market under the ticker symbol “ALOY.” The transaction marks the ...

If you purchased or acquired Fermi: (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s October 2025 initial public offering (“IPO” or the “Offering”); and/or (b) securities between October 1, 2025 and December 11, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate i ...

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Commvault Systems, Inc. (“Commvault” or the “Company”) (NASDAQ: CVLT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Commvault and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On J ...

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brown & Brown, Inc. (“Brown & Brown” or the “Company”) (NYSE: BRO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Brown & Brown and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On J ...

GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) announced today that it will hold a conference call to discuss fourth quarter 2025 earnings on Tuesday, March 3, 2026 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-715-9871, access code number 4928384. There will be a recorded replay of the call available for 30 days after the call. If you are interested in hearing the recording, please dial 1-800-770-2030. Th ...